BUZZ-Abivax pops 19% on market talk about Eli Lilly takeover interest** Shares in French biotech company Abivax ABVX.PA up as much as 19% with two traders citing market speculation about potential takeover interest from Eli Lilly LLY.N
** Abivax and Eli Lilly were not immediately available for comment
** If gains hold, Abivax will add 1.5 billion euros to its market value of 7.8 billion euros ($9.1 billion)
($1 = 0.8592 euros)
(Reporting by Gianluca Lo Nostro; editing by Danilo Masoni)
((gianluca.lonostro@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments